Insight Molecular Diagnostics annual revenue
2020
2021
2022
2023
2024
2025
Insight Molecular Diagnostics Revenue Growth & History (IMDX)
Insight Molecular Diagnostics reported $4.1M in revenue for fiscal 2025, an increase of 115.58% from the previous fiscal year.
View full Insight Molecular Diagnostics company overviewInsight Molecular Diagnostics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4.1M | $2.2M | +115.58% |
| 2024 | 2024-12-31 | $1.9M | $378,000 | +25.15% |
| 2023 | 2023-12-31 | $1.5M | $545,000 | +56.89% |
| 2022 | 2022-12-31 | $958,000 | −$1.2M | −56.41% |
| 2021 | 2021-12-31 | $2.2M | $982,000 | +80.76% |
| 2020 | 2020-12-31 | $1.2M | — | — |
Insight Molecular Diagnostics quarterly revenue
Q1.16
Q2.16
Q3.16
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $239,000 | −$279,000 | −53.86% |
| Q1 2026 | 2026-03-31 | $32,000 | −$2.1M | −98.50% |
| Q4 2025 | 2025-12-31 | $1.1M | −$347,000 | −23.35% |
| Q3 2025 | 2025-09-30 | $260,000 | $145,000 | +126.09% |
| Q2 2025 | 2025-06-30 | $518,000 | $414,000 | +398.08% |
| Q1 2025 | 2025-03-31 | $2.1M | $2.0M | +1114.77% |
| Q4 2024 | 2024-12-31 | $1.5M | $1.2M | +373.25% |
| Q3 2024 | 2024-09-30 | $115,000 | −$314,000 | −73.19% |
| Q2 2024 | 2024-06-30 | $104,000 | −$359,000 | −77.54% |
| Q1 2024 | 2024-03-31 | $176,000 | −$121,000 | −40.74% |
| Q4 2023 | 2023-12-31 | $314,000 | $40,000 | +14.60% |
| Q3 2023 | 2023-09-30 | $429,000 | $362,000 | +540.30% |
| Q2 2023 | 2023-06-30 | $463,000 | $226,000 | +95.36% |
| Q1 2023 | 2023-03-31 | $297,000 | −$83,000 | −21.84% |
| Q4 2022 | 2022-12-31 | $274,000 | −$3.3M | −92.37% |
| Q3 2022 | 2022-09-30 | $67,000 | −$917,000 | −93.19% |
| Q2 2022 | 2022-06-30 | $237,000 | −$1.8M | −88.33% |
| Q1 2022 | 2022-03-31 | $380,000 | −$744,000 | −66.19% |
| Q4 2021 | 2021-12-31 | $3.6M | $3.1M | +613.52% |
| Q3 2021 | 2021-09-30 | $984,000 | $429,000 | +77.30% |
| Q2 2021 | 2021-06-30 | $2.0M | $1.9M | +1319.58% |
| Q1 2021 | 2021-03-31 | $1.1M | $1.1M | +6925.00% |
| Q4 2020 | 2020-12-31 | $503,000 | — | — |
| Q3 2020 | 2020-09-30 | $555,000 | — | — |
| Q2 2020 | 2020-06-30 | $143,000 | — | — |
| Q1 2020 | 2020-03-31 | $16,000 | — | — |
| Q3 2016 | 2016-09-30 | $0 | — | — |
| Q2 2016 | 2016-06-30 | $0 | — | — |
| Q1 2016 | 2016-03-31 | $0 | — | — |
Insight Molecular Diagnostics revenue growth trends
Over the last five reported fiscal years, revenue grew from $1.2M to $4.1M, a compound annual growth rate of 27.24%. Insight Molecular Diagnostics's latest reported quarter, Q2 2026, generated $239,000 in revenue, a decrease of 53.86% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Insight Molecular Diagnostics source filings ↗